Literature DB >> 1864486

Relationship between serum pseudocholinesterase and triglycerides in experimentally induced diabetes mellitus in rats.

V Annapurna1, I Senciall, A J Davis, K M Kutty.   

Abstract

This study was designed to understand the reasons for the increase in serum pseudocholinesterase activity in diabetes mellitus. Streptozotocin-induced diabetic rats were used for the study. Serum pseudocholinesterase activity increased with the induction of diabetes (381.5 units/l +/- 11.8) compared to the non-diabetic rats (243.1 units/l +/- 7.2). Serum triglycerides, total low density lipoprotein and glycerol also increased concurrently with the development of diabetes. Insulin treatment of the diabetic rats normalized serum glucose concomitant with the reduction of pseudocholinesterase activity, triglycerides, total low density lipoprotein and glycerol. Heparin injection appeared to activate lipoprotein lipase in the diabetic rats by showing a marked fall in serum triglyceride and total low density lipoprotein levels but not in pseudocholinesterase activity. Administration of tetraisopropylpyrophosphoramide a specific pseudocholinesterase inhibitor, inhibited serum and adipose tissue pseudocholinesterase activity by greater than 80% and liver greater than 50%. Concurrent with the inhibition of pseudocholinesterase activity serum triglyceride, low density lipoprotein and glycerol decreased significantly. In normal rats treatment with tetraisopropylpyrophosphoramide also reduced serum lipoproteins markedly, while glycerol only showed a marginal decrease. Glycerol was used as a marker of adipose tissue lipolysis and total low density lipoprotein which is defined as lipoproteins of density less than 1.063 (LDL + VLDL).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1864486     DOI: 10.1007/bf00405003

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  29 in total

1.  The effect of acute insulin deficiency in the rat on adipose tissue lipolytic activity and plasma lipids.

Authors:  J D SCHNATZ; R H WILLIAMS
Journal:  Diabetes       Date:  1963 Mar-Apr       Impact factor: 9.461

Review 2.  Role of insulin and other hormones in the control of lipoprotein lipase activity.

Authors:  D S Robinson; B K Speake
Journal:  Biochem Soc Trans       Date:  1989-02       Impact factor: 5.407

3.  Effects of streptozotocin on carbohydrate and lipid metabolism in the rat.

Authors:  P S Schein; K G Alberti; D H Williamson
Journal:  Endocrinology       Date:  1971-09       Impact factor: 4.736

4.  Quantitative determination of serum triglycerides by the use of enzymes.

Authors:  G Bucolo; H David
Journal:  Clin Chem       Date:  1973-05       Impact factor: 8.327

5.  Pseudocholinesterase in obese and hyperlipemic subjects.

Authors:  M Cucuianu; T A Popescu; S Haragus
Journal:  Clin Chim Acta       Date:  1968-10       Impact factor: 3.786

6.  Purification and properties of human serum cholinesterase.

Authors:  P K Das; J Liddell
Journal:  Biochem J       Date:  1970-03       Impact factor: 3.857

7.  Serum pseudocholinesterase: high density lipoprotein cholesterol ratio as an index of risk for cardiovascular disease.

Authors:  K M Kutty; R Jain; S Huang; K Kean
Journal:  Clin Chim Acta       Date:  1981       Impact factor: 3.786

8.  Pseudocholinesterase in obesity: hypercaloric diet induced changes in experimental obese mice.

Authors:  K M Kutty; S N Huang; K T Kean
Journal:  Experientia       Date:  1981-11-15

9.  Lipid synthesis, intracellular transport, storage, and secretion. I. Electron microscopic radioautographic study of liver after injection of tritiated palmitate or glycerol in fasted and ethanol-treated rats.

Authors:  O Stein; Y Stein
Journal:  J Cell Biol       Date:  1967-05       Impact factor: 10.539

View more
  5 in total

1.  GWAS of butyrylcholinesterase activity identifies four novel loci, independent effects within BCHE and secondary associations with metabolic risk factors.

Authors:  Beben Benyamin; Rita P Middelberg; Penelope A Lind; Anne M Valle; Scott Gordon; Dale R Nyholt; Sarah E Medland; Anjali K Henders; Andrew C Heath; Pamela A F Madden; Peter M Visscher; Daniel T O'Connor; Grant W Montgomery; Nicholas G Martin; John B Whitfield
Journal:  Hum Mol Genet       Date:  2011-08-23       Impact factor: 6.150

2.  Cholinesterase and paraoxonase (PON1) enzyme activities in Mexican-American mothers and children from an agricultural community.

Authors:  Veronica Gonzalez; Karen Huen; Subha Venkat; Kelly Pratt; Pin Xiang; Kim G Harley; Katherine Kogut; Celina M Trujillo; Asa Bradman; Brenda Eskenazi; Nina T Holland
Journal:  J Expo Sci Environ Epidemiol       Date:  2012-07-04       Impact factor: 5.563

3.  The Correlative Study of Serum Pseudo-cholinesterase, Biological Parameters and Symptoms Among Occupational Workers.

Authors:  Tanasorn Tunsaringkarn; Kalaya Zapuang; Anusorn Rungsiyothin
Journal:  Indian J Clin Biochem       Date:  2013-04-03

Review 4.  Apolipoprotein E and lipid homeostasis in the etiology and treatment of sporadic Alzheimer's disease.

Authors:  Judes Poirier; Justin Miron; Cynthia Picard; Patrick Gormley; Louise Théroux; John Breitner; Doris Dea
Journal:  Neurobiol Aging       Date:  2014-05-15       Impact factor: 4.673

5.  Butyrylcholinesterase as a prognostic marker: a review of the literature.

Authors:  Lidia Santarpia; Ilenia Grandone; Franco Contaldo; Fabrizio Pasanisi
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-09-06       Impact factor: 12.910

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.